Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
SKU
C01903-5mg
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FP692014-01 50 µg
Anti-Cat Fel d 1B/CH2/Allergen FdI Polyclonal Antibody
Sign In for Pricing
View Details FP692014-02 100 µg
Anti-Cat Fel d 1B/CH2/Allergen FdI Polyclonal Antibody
Sign In for Pricing
View Details 
C2262-43K-01 50 µg
CD11b (Cell Surface Glycoprotein MAC1 Alpha Subunit, Complement Component Receptor 3 Alpha, CR3A, ITGAM, MAC1A, MO1A, Neutrophil Adherence Receptor)
Sign In for Pricing
View Details C2262-43K-02 500 µg
CD11b (Cell Surface Glycoprotein MAC1 Alpha Subunit, Complement Component Receptor 3 Alpha, CR3A, ITGAM, MAC1A, MO1A, Neutrophil Adherence Receptor)
Sign In for Pricing
View Details 
GTR15254114 1 Vial
Lentiviral mouse Pax7 shRNA (UAS) - Lentiviral mouse Pax7 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details